TY - JOUR
T1 - Frequency of periprocedural myocardial injury and infarction stratified by cardiac troponin I and cardiac troponin T
AU - Revaiah, Pruthvi C.
AU - Tsai, Tsung Ying
AU - Wang, Bo
AU - Renkens, Mick
AU - Kageyama, Shigetaka
AU - Wlodarczak, Adrian
AU - Lemoine, Julien
AU - Mollmann, Helge
AU - Sabate, Manel
AU - Sharif, Faisal
AU - Zaman, Azfar
AU - Wykrzykowska, Joanna
AU - Benit, Edouard
AU - Qiang, He Xing
AU - Miyashita, Kotaro
AU - Tobe, Akihiro
AU - Muramatsu, Takashi
AU - Tanabe, Kengo
AU - Ozaki, Yukio
AU - Garg, Scot
AU - McEvoy, John William
AU - Neumann, Franz Josef
AU - Baumbach, Andreas
AU - Smits, Peter C.
AU - Stone, Gregg
AU - Onuma, Yoshinobu
AU - Serruys, Patrick W.
N1 - Publisher Copyright:
© 2024
PY - 2024
Y1 - 2024
N2 - Background: There are different definitions of periprocedural myocardial infarction (PPMI) both in terms of thresholds for cardiac biomarkers and the ancillary criteria for myocardial ischemia. Cardiac Troponin I (cTnI) and cardiac Troponin T (cTnT) are used interchangeably to diagnose PPMI. Objectives: This study evaluated the frequency of periprocedural myocardial injury and infarction as defined by the Society of Cardiovascular Angiography & Interventions (SCAI), the Academic Research Consortium-2 (ARC-2), and the 4th Universal definition of MI (4UDMI) stratified using cTnT versus cTnI, among patients with chronic coronary syndrome (CCS) and unstable angina. Results: Among 830 patients, PPMI rates according to the SCAI, ARC2 and 4UDMI criteria were 4.34 %, 2.05 %, and 4.94 % respectively, with higher rates seen for all definitions when using cTnI versus cTnT (SCAI: 9.84 % vs. 1.91 %, p < 0.001; ARC 2: 3.15 % vs. 1.56 %, p = 0.136; and 4UDMI 5.91 % vs. 4.51 %, p = 0.391). Minor and major periprocedural myocardial injury was respectively observed in 58.31 % and 27.10 % of patients, with rates of both significantly higher when using cTnI versus cTnT (Minor: 69.29 % vs. 53.47 %, p < 0.001, Major: 49.21 % vs. 17.36 %, p < 0.001). Conclusions: Among patients with CCS and unstable angina, PPMIs defined by SCAI occurred more frequently when using cTnI as opposed to cTnT, whereas the type of troponin had no impact on the incidence of PPMIs according to the ARC-2 and 4UDMI.
AB - Background: There are different definitions of periprocedural myocardial infarction (PPMI) both in terms of thresholds for cardiac biomarkers and the ancillary criteria for myocardial ischemia. Cardiac Troponin I (cTnI) and cardiac Troponin T (cTnT) are used interchangeably to diagnose PPMI. Objectives: This study evaluated the frequency of periprocedural myocardial injury and infarction as defined by the Society of Cardiovascular Angiography & Interventions (SCAI), the Academic Research Consortium-2 (ARC-2), and the 4th Universal definition of MI (4UDMI) stratified using cTnT versus cTnI, among patients with chronic coronary syndrome (CCS) and unstable angina. Results: Among 830 patients, PPMI rates according to the SCAI, ARC2 and 4UDMI criteria were 4.34 %, 2.05 %, and 4.94 % respectively, with higher rates seen for all definitions when using cTnI versus cTnT (SCAI: 9.84 % vs. 1.91 %, p < 0.001; ARC 2: 3.15 % vs. 1.56 %, p = 0.136; and 4UDMI 5.91 % vs. 4.51 %, p = 0.391). Minor and major periprocedural myocardial injury was respectively observed in 58.31 % and 27.10 % of patients, with rates of both significantly higher when using cTnI versus cTnT (Minor: 69.29 % vs. 53.47 %, p < 0.001, Major: 49.21 % vs. 17.36 %, p < 0.001). Conclusions: Among patients with CCS and unstable angina, PPMIs defined by SCAI occurred more frequently when using cTnI as opposed to cTnT, whereas the type of troponin had no impact on the incidence of PPMIs according to the ARC-2 and 4UDMI.
KW - Cardiac troponin I (cTnI)
KW - Cardiac troponin T (cTnT)
KW - Periprocedural myocardial infarction (PMI)
UR - http://www.scopus.com/inward/record.url?scp=85194061996&partnerID=8YFLogxK
U2 - 10.1016/j.carrev.2024.05.022
DO - 10.1016/j.carrev.2024.05.022
M3 - Article
AN - SCOPUS:85194061996
SN - 1553-8389
JO - Cardiovascular Revascularization Medicine
JF - Cardiovascular Revascularization Medicine
ER -